What is Joint Active Systems?
Joint Active Systems operates at the intersection of biomechanical engineering and patient-centric healthcare. The company specializes in the development and distribution of advanced range of motion devices, including dynamic and static progressive stretch braces designed for complex upper and lower extremity conditions. By providing clinically supported solutions for joints such as the shoulder, knee, and elbow, the firm addresses critical gaps in functional recovery. Their business model, which targets a tripartite audience of healthcare professionals, patients, and insurance adjusters, emphasizes precise measurement and customization to drive superior patient outcomes and long-term mobility improvements.
How much funding has Joint Active Systems raised?
Joint Active Systems has raised a total of $2.1M across 2 funding rounds:
Debt
$1M
Debt
$1.1M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.1M led by PPP
Key Investors in Joint Active Systems
PPP
Public-Private Partnership
What's next for Joint Active Systems?
With the recent infusion of capital, Joint Active Systems is well-positioned to accelerate its enterprise-level growth strategy. The company is expected to leverage these resources to expand its clinical research initiatives and enhance its distribution network, ensuring that its therapeutic solutions reach a broader demographic of patients suffering from limited mobility. As the healthcare sector increasingly prioritizes value-based care and measurable recovery metrics, the firm's commitment to data-driven orthopedic solutions provides a significant competitive advantage. Future developments will likely focus on scaling manufacturing capabilities and integrating digital health monitoring to further optimize the efficacy of their progressive stretch technology.
See full Joint Active Systems company page
